Australian biopharma firm CSL posts 14% rise in annual profit
ReutersAug 18, 2025 9:49 PM
Aug 19 (Reuters) - Australian biopharmaceutical company CSL CSL.AX reported 14% rise in annual earnings on Tuesday, driven by strong performance at its blood plasma business CSL Behring.
The world's second-largest producer of flu vaccines reported net profit after tax attributable for the year ended June 30 of $3.3 billion on a constant currency basis, higher than $3.01 billion reported last year.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Circle’s Next Chapter: Not Just Stablecoins, But a Payments Network
TradingKey - Stablecoins are meeting real-world demand, especially in emerging markets where payment systems are oftenfragmented, access to the traditional banking system is limited, or capital controls restrict seamless global flows.TradingKey
17 hours ago
Investing in Robotics & Automation
Robotics and automation are a structural megatrend driven by labor shortages, supply chain shifts, and the push for efficiency.The investment landscape spans industrial leaders, healthcare innovators, logistics adopters, and semiconductor enablers.TradingKey
Sat, Sep 20
What is BNB? Can CZ's Return to Binance Propel It to $2700?
It’s also worth noting that 2028 marks Bitcoin’s fifth halving — a historically bullish catalyst. If past cycles repeat, BNB could ride the wave to new highs. Considering macroeconomic trends, supply dynamics, CZ’s potential return, and the next bull market, Standard Chartered’s target seems increasTradingKey
Fri, Sep 19
[Reuters Analysis] Heightened uncertainties feed Fed inconsistencies: McGeever
By Jamie McGeever ORLANDO, Florida, Sept 18 (Reuters) - The Federal Reserve cut interest rates on Wednesday for the first time in nine months, arguing the move is necessary to counter increasing risks to the labor market. The rationale is sound enough. There's only one problem - it seems to c...Reuters
Fri, Sep 19
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
Tradingkey
